Each Person Is a Statistic of One
When Miggie Olsson was diagnosed with stage IV pancreatic cancer she opted for a science-based unusual treatment plan to have a chance at survival.
When Miggie Olsson was diagnosed with stage IV pancreatic cancer she opted for a science-based unusual treatment plan to have a chance at survival.
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
Dr. Shaalan Beg describes a clinical trial using the kinase inhibitor bemcentinib along with chemotherapy as a way to slow down or stop pancreatic cancer.
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.